More importantly, our results uncovered that shikonin possessed the suppressive effects on ECC cells via blocking miR-106b/PTEN/AKT/mTOR signaling pathway, suggesting shikonin could act as a promising anticancer agent for EEC treatment. The gene discussed is MTOR; the disease is exstrophy-epispadias complex.